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Abstract

Designer drugs are structural analogs of Drug Enforcement Agency (DEA) Schedule I and II
substances. They are synthesized to mimic the effects of illegal drugs of abuse and to bypass the
provisions of drug regulations. Despite the increased availability of designer drugs, few studies
have focused on specific analytical extraction techniques for their detection and quantification in
biological samples. Solid phase extraction (SPE) is the most commonly used technique for
sample preparation. The purpose of this study is to evaluate the extraction efficiency of the
various SPE columns with different sorbent materials for two designer drugs, cathinone and
mephedrone in sheep plasma using LC-MS/MS as well as to evaluate the standard addition
quantification technique. SPE columns used in this study were Phenomenex Strata X-C strong
cation mixed mode column, Phenomenex Strata X Drug B strong cation mixed mode column and
SupelTM HLB hydrophilic modified styrene polymer column. The Phenomenex Strata X-Drug B
strong cation cartridge was found to have the best retention profile for our analytes. Percent
recovery of initial cathinone concentration was 137.6, 93.6 and 103.6% for 10, 33 and 100ng/mL
cathinone respectively using the standard addition method with the X-intercept and 120.9, 91.1
and 103.2% with calculations based on the Y-intercept. Percent recovery of initial mephedrone
concentration was 191.9, 105.7 and 116.7% for 10, 33 and 100ng/mL mephedrone respectively
using the standard addition method with the X-intercept and 153.5, 97.1 and 115.1% using the
Y-intercept.
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INTRODUCTION
Cathinones
The Controlled Substances Act, Title II of the Comprehensive Drug Abuse Prevention and
Control Act of 1970 made it illegal to manufacture, import, possess, use or distribute certain
types of “scheduled drugs”. The scheduling of drugs puts substances into categories based on
their therapeutic capability and potential for abuse (U.S. Department of Health and Human
Services, 2009). This act unknowingly prompted a dramatic shift in the drug market. In the
1970s the philosophy of illicit drug synthesis underwent a very sophisticated change. Soon many
clandestine laboratories that previously only synthesized illicit drugs began to aggressively
develop structural analogs of them. The development of compounds that interact in very similar
ways and yield effects that closely resemble that of their illicit precursors created a new type of
drug market. This would change the way that synthetic drugs are created, detected and policed.
The term “Designer Drug” was adopted to describe the way that these substances are altered
specifically to mimic the psychological and physiological properties of illicit drugs and to also
maneuver around law and regulation (DeCaprio, Hearn, & Swortwood, 2013).
In the late 1970’s -methyl-fentanyl began to cause its first overdoses in Los Angeles and by
1985 at least eleven other chemical analogs had been found to be marketed as heroin. Alphamethyl-fentanyl was created by a simple chemical modification to Fentanyl, a powerful narcotic
analgesic first synthesized in Belgium in the 1960s (Henderson, 1988). The methylated carbon
that differentiates the two compounds, albeit a small alteration accomplished two things. The
modification accounted for an increase in potency by a factor of two. It denotes a compound that
is more potent, but not an identical copy of an illicit pharmaceutical. Therefore this modified

compound was not subjected to toxicological review and testing. 3-methylfentanyl is another
example and was introduced in the spring of 1984 with only one methyl group difference from
-methylfentanyl. Although the structure was very similar to other analogs, it was found to be
far more potent and perhaps the most potent narcotic analgesic of the time. The drug vanished
from the market only months after surfacing. At 400-600 times as potent as morphine depending
on the isomer, it is believed to be largely responsible for the 5-fold increase in fentanyl overdose
deaths from 1983-1984 (Henderson, 1988). The problem for law and drug officials was that
structural analogs of pharmaceuticals can vary dramatically in terms of toxicity, can bypass
standard drug screens and most importantly are not illegal. Since the 1970s and 80s the designer
drug market has grown exponentially. From synthetic cannabinoids to opiate derivatives to
altered amphetamine-like compounds, the industry has no incentive to slow down or concentrate
on any one class of drug.
The Federal Analogue Act of 1986 was an addition to the controlled substances act that
attempted to blanket the quickly growing designer drug industry by treating any substance that is
“substantially similar” to any schedule I or II drug as if it too were scheduled the same
(Sathappen, 2013). The only caveat of this regulation is that it only applies to substances
intended for human consumption. Since the passage of this act, drug manufacturers have
marketed many designer drugs as other products, specifically labeling them as “not for human
consumption” while knowingly distributing them to smoke shops and retailers of questionable
recreational paraphernalia.
Cathinone is found naturally in the Khat plant Catha Edulis, an evergreen shrub from the
Celastraceae family. The Khat plant is native to the horn of Africa and the Arabian Peninsula.
For centuries the plant has been used for its psychoactive stimulant properties. The oval leaves
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and shoots of the Khat plants are often chewed or used to brew tea (Lemieux, Bingshuo, &
al’Absi, 2015). The use of Khat in areas of Yemen and Ethiopia are deeply woven into the
culture. It is viewed as a traditional norm and the associated effects are likened to that of
caffeine. The Khat plant contains 62 alkaloids but only two of them, cathine and cathinone have

Cathinone

Amphetamine

been found to be psychoactive. The stimulant properties of cathinone resemble that of
amphetamine, another central nervous system stimulant (Coppola & Mondola, 2012). Cathinone
is lipophilic and readily crosses the blood-brain barrier. However, the ketone on the 2nd carbon
makes the molecule slightly more polar than amphetamine and accounts for why cathinone is
less potent. Structurally cathinone and amphetamine differ very little (Figure 1).
Figure 1: Chemical structure of Cathinone and Amphetamine.
Both compounds consist of a linear chain of three carbons with a phenyl group attached to the 1st
carbon and an amino group attached to the 2nd. The two molecules differ only by the ketone on
the 2nd carbon of cathinone. The psychoactive effects of cathinone and amphetamine are due to
the interferences with the monoamine neurotransmitter systems, primarily the dopaminergic and
norepinephrenergic systems (Coppola & Mondola, 2012). Both compounds function as
monoamine transporter substrates, which increase the amount of dopamine and norepinephrine
present at the synaptic clef. Unlike monoamine re-uptake inhibitors which prevent
neurotransmitter reabsorption, these substrates more effectively populate the synapse by
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promoting the release of neurotransmitters and are not dependant on their ongoing exocytotic
release (Rothman & Baumann, 2006).
When cathinone enters the body the psychotropic effects begin to occur within an hour and the
peak plasma concentration is typically reached between 1.5 and 3.5 hours after ingestion.
Cathinone undergoes first pass metabolism where it converted to its principle metabolite,
norephedrine in the liver. Less than 2% of unmodified parent drug is excreted into urine (Prosser
& Nelson, 2012). Cathinone use in humans prompts to increase blood pressure, heart rate and
psychomotor activity. At moderate doses it can cause increases in sociability, energy, libido and
perceived sexual performance and low level increases in euphoria and empathy (Coppola &
Mondola, 2012).
The first synthetic analogs of cathinone were developed in the 1920s. Methcathinone and
mephedrone (4-methlymethcathinone) were both derived from the naturally occurring cathinone
of the Khat plant. These “cathinones” were not found to have therapeutic applications to
overcome some of their associated side effects so research into them was largely abandoned by
the pharmaceutical industry. Beginning in the early 2000s however these drugs began to reappear
in the designer drugs of abuse market (Coppola & Mondola, 2012). Synthetic cathinones are
largely marketed as “bath salts”, “plant food” or “research chemicals” with labels that
specifically indicate “not intended for human consumption”. Anyone can easily consult the
internet for information about new “legal highs” and how to obtain them. So the precautions
taken by clandestine drug manufacturers are meant not to protect the consumer but to protect
themselves and dealers from prosecution. These so called “legal highs” are all substitutes for
other established stimulants; cocaine, ecstasy and methamphetamine. Like these drugs, synthetic
cathinones also share many of the same symptoms of acute intoxication. Psychomotor agitation,
8

parkinsonism, tremors, tachycardia, hypertension, delusions and paranoid psychosis, abdominal
pain, kidney damage, cerebral edema, seizures, duodenal ulcers and excited delirium are only
some of the effects observed at higher doses (Prosser & Nelson, 2012) (Blum, et al., 2013)
(Ellefsen, et al., 2014). Many of these drugs are sold in cocktail form containing multiple active
drugs and byproducts of incomplete or sloppy synthesis. A 2014 study analyzing 14 street
samples marketed as “bath salts”, “plant food” or “jewelry cleaner” found ten different synthetic
cathinones. 4-flouromethcathinone (4-FMC), 3,4-methylenedioxy-α-pyrrolidinobutiophenone
(MDPBP), mephedrone, butylone, naphyrone, 4-methylethcathinone (4-MEC), ethcathinone, αpyrrolidinopentiophenone (α-PVP), MDPV and 3-methyl-α-pyrrolidinopropiophenone (3-MPPP)
were all detected at various concentrations (Leffler, Smith, de Armas, & Dorman, 2014). MDPV
was detected in 5 of the 14 samples making it the most common analyte. The majority of those
samples contained only one single active compound but three of the samples contained between
3 and 5 different synthetic cathinones. The actual synthetic cathinone concentration varied from
sample to sample. Concentrations were found as low as 11% and as high as 85% in the 14
samples of the study. The varied concentrations, their respective potencies and mechanisms of
action result in products that can cause unpredictable toxic effects.
The first “bath salts” restriction by the DEA through the emergency scheduling authority was for
methylenedioxypyrovalerone (MDPV), Mephedrone and Methylone on September 7, 2011 and
temporarily placed them in the schedule I category. Schedule I drugs are found to have no
accepted medical or therapeutic use and have the highest potential for abuse. The scheduling
process is conducted by the Drug Enforcement Agency (DEA) and begins with an investigation
of a drug or substance that incorporates finding and recommendations from the National Institute
of Drug Abuse, the Department of Health and Human Services (DHHS), the Food and Drug
9

Administration (FDA) and on some occasion the medical and scientific community at large. The
Synthetic Drug Abuse Prevention Act was signed into law in 2012 and formally categorized
these three cathinones as schedule I controlled substances and doubled the amount of time that
the DEA can administratively schedule any substance from 18 to 36 months.
Accurate determination of plasma concentration of these cathinones is critically important for
DEA regulation and enforcement. Therefore, the effective extraction and precise detection of
cathinones in plasma will help in controlling these substances.

Solid phase extraction (SPE)
Solid phase extraction (SPE) is the most widely used sample preparation method in modern
forensic toxicology due to it is cheap, quick, reproducible, and less solvent consumption. But its
roots extend back millennia even those employing it were unaware of what was taking place.
From the use of animal charcoal, zeolites and diatomaceous earth to C18 bonded silica, SPE has
been used to adequately bridge the gap between the sample and the analysis step.
Homogenization, filtration, distillation, precipitation, pH adjustment, concentration and
reconstitution are just a few of the techniques used to accomplish this. More often than not a
combination of these steps is used to get a sample into the appropriate state for instrumental
analysis. Modern SPE accomplishes several of these steps in a simple and straight forward way
that leaves less room for error and allows for large increases in efficiency and throughput, while
enhancing the benefits of each separate process. In total the main goals of SPE are to remove
unwanted molecules from the sample, remove the sample matrix and to concentrate the target
analyte. The fundamental difference between solid phase extraction and liquid/liquid extraction
10

is that a SPE sorbent material replaces the liquid solvent used and the distribution coefficient
describes the equilibrium reached between the analyte and the sorbent material rather than the
analyte and the liquid solvent. The retention of the target analyte to the sorbent is accomplished
by simple adsorption or by analyte migration through the outer layer of molecules on the surface
of the solid. If conditions are reached where the distribution coefficient is extremely high at
equilibrium, then virtually all of the analyte molecules will be retained by the sorbent material.
Conventional SPE motifs are in the form of cartridge columns where samples are passed through
a bed of solid sorbent particles. Once the analyte is retained, it can then be eluted with a suitable
solvent whereby having been largely separated from the sample matrix and in a state that is more
compatible for instrumentation.
There are multiple types of SPE, normal phase, reversed phase, ion-exchange and adsorption.
Normal phase SPE employs a polar modified solid phase and a non-polar mobile or liquid phase.
Retention is based on the hydrophilic polar/polar interactions, hydrogen bonding, pi-pi, dipole
and dipole-induced dipole interactions between analytes and the sorbent material. In this form of
chromatography polar compounds are retained while non-polar compounds are eluted first. In the
more widely used reversed phase SPE hydrophobic non-polar/non-polar interactions and van der
Waals forces are responsible for retention with a non-polar modified solid phase and a polar
mobile phase. Reverse phase SPE is less selective than other forms of SPE and is used to retain a
wider range of compounds. Ion-exchange SPE makes use of electrostatic interactions between
charged analytes and a charged sorbent particle surface to retain target sample components.
Adsorption SPE can be run under reversed or normal phase conditions however unmodified
sorbent material is used and a combination of hydrophobic and hydrophilic interactions may take
place depending on the pH range employed. Mixed mode SPE are typically columns that employ
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a combination of modified sorbent material that can rely on cation/anion exchange in addition to
hydrophobic/hydrophilic interactions (Supelco, 1998) (Juhascik & Jenkins, 2009).
Enzyme Multiplied Immunoassay Technique (EMIT)
The toxicological issues associated with this designer drug war largely focus on the qualitative
and quantitative analysis of these substances. The development of high throughput screening
methods to quickly identify the presence of synthetic cathinones is an area of much interest. The
development of immunoassays with selective antibody affinity is in high demand but remain
very difficult to produce. Samples containing multiple compounds of interest are not always
compatible with antibodies that show only supplemental affinity to structurally similar antigens.
“Group specificity” can only be taken so far in terms of cross reactivity. In addition, the time
needed to produce the antibodies necessary may exceed the time that a particular drug remains
on the market. Due to this imbalance of applicable research and demand some professionals have
looked into molecular modelling of designer drugs as a tool for predicting immunoassay crossreactivity (Petrie, et al., 2013). Currently there is only one commercially available immunoassay
for synthetic cathinones in urine. Randox Drugs of Abuse V Biochip Array contains specific
antibodies for methcathinone, mephedrone, MDPV and MDPBP. Cross reactivity was observed
in a validation study of this immunoassay where 20,017 authentic. U.S military urine samples
were analyzed for 28 other synthetic cathinones (Ellefsen, et al., 2014).
Tracing the stability of these compounds and their metabolites in various matrices and storage
environments is another area of great importance. While it is widely understood that refrigerated
storage greatly improves the overall stability of a variety of drugs of abuse, some synthetic
cathinones including cathinone and mephedrone present in whole blood are especially
susceptible to rapid degradation if not immediately frozen (Sørensen, 2011). This may be
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possible for the majority of cases involving acute intoxication where remains can be quickly
collected and catalogued but for other situations this and other investigations into stability could
prove useful. The one caveat that research into drug screening and stability does not take into
consideration is extraction efficiency.
LC-MS/MS
In forensic toxicology it is important to be able to detect drugs at toxic concentrations but it is
equally important to detect and accurately quantify drugs at therapeutic concentrations. In a
growing industry of automation and high throughput liquid/liquid extraction is not always
preferable. With the drawbacks of variability in recovery, the use of large quantities of organic
solvents and the need for precise hand-eye coordination makes solid phase extraction the best
option. Extraction efficiency is largely based on recovery. Among the factors that determine
recovery are matrix effects. A sample matrix is defined as all components of a sample other than
the specific target compound(s). Matrix effects are the combined effects of these components on
the quantitative analysis of the target compound(s). The overall extraction process involves all
steps from untreated biological specimen to concentrated and isolated target compounds. LCMS
is the most important modern analytical technique in forensic toxicology and is a direct way to
evaluate the extraction process. Electrospray ionization has become the most widely used
technique for coupling liquid chromatography and mass spectroscopy for its simplicity and
applicability. Matrix effects do however constitute a significant drawback in terms of ion signal
with ESI. Matrix-dependent ion suppression or enhancement can produce erroneous results when
analyzing extraction recovery. While there are few proposed causes of ionization enhancement
its suppression in electrospray ionization is attributed to the presence of non-volatile matrix
components such as salts and sulphates that inhibit the release of charged gaseous ions. These
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components cause an increase in solute surface tension and viscosity which affect solvent
evaporation and the overall force holding nebulized drops together. These co-eluting matrix
components also negatively affect ion production by outcompeting analytes for the limited
charge and by co-precipitating analytes. These matrix/analyte precipitates and unevaporated
solvent portions collect on the interface plates of mass analyzers. Gas phase reactions between
matrix components and analytes can also cause the loss of charge of analyte ions.
Aim
In this study target compounds (s)-cathinone and two synthetic analogs, mephedrone and MDPV
were used in evaluating the extraction process efficiency of three solid phase extraction columns.
The Strata X-C strong cation mixed mode column, Strata X Drug B strong cation mixed mode
column and SupelTM HLB hydrophilic modified styrene polymer column were used. Strata X-C
has numerous retention mechanisms such as hydrophobic, dipole-dipole, - and strong cation
exchange. Strata X Drug B designed to meet Substance Abuse and Mental health Services
Administration (SAMHSA) regulations is a mixed mode column for wide range of basic drugs.
The retention mechanism of SupelTM HLB is based on reversed-phase interaction; however,
because the phase is hydrophilic modified, the phase is also selective for more polar compounds.
After an initial evaluation of these three SPE cartridges by LCMS the study focused on the
performance of the Strata X Drug-B cartridge. The overall extraction efficiency of this cartridge
was determined by comparing drug recovery of neat samples and extracted samples in methanol
and matrix effect influence in sheep plasma. In addition to studying the extraction process
efficiency of the SPE cartridge a standard addition quantifying technique was also assessed as an
alternative to internal standard quantification for synthetic cathinone recovery in sheep plasma.
Methods and Materials
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Chemicals and reagents
Reference standard materials consisting of: 4-methylmethcathinone (mephedrone), s-cathinone,
3,4-methylenedioxypyrovalerone (MDPV) and 4-methylephedrine in methanol (1 mg/ml) were
purchased from Cerilliant Analytical Reference StandardsTM (Round Rock, TX, USA).
Deuterated mephedrone (mephedrone d3; 100 µg/ml) from Cerilliant Analytical Reference
StandardsTM was used as internal standard.
Viva-Jr® Drug testing system (Siemens, Newark, DE) was used for Enzyme Multiplied
Immunoassay to presumptively detect the presence of cathinones. The amphetamine assay with
three cutoffs 300, 500 and 1000 ng/ml d-methamphetamine and the ecstasy assay with two
cutoffs 300 and 500 ng/ml MDMA from Siemens were chosen for this study. Calibrators (Level
0, 3 and 5) obtained from Siemens were used to calibrate the system.
Solid phase extraction (SPE) cartridges used were Phenomenex Strata X-C, Phenomenex
Strata X-Drug B, and Supelco Supel-Select HLB (Hydrophilic Lipophilic Balance).
Phenomenex Strata X-C is a strong cation mixed mode SPE cartridge for weakly basic
compounds. Phenomenex Strata X-Drug B is a strong cation mixed mode SPE for basic drugs
of abuse. Supelco Supel-Select HLB is a hydrophilic modified styrene-based polymer SPE
which retains chemicals based on reverse phase mechanism. However, with hydrophilic
modification on Supelco Supel-Select HLB some polar compounds can also be extracted.
Water was filtered using Millipore water purification system. HPLC reagent grade methanol was
from Thermo Fisher Scientific. Reagent grade formic acid, glacial acetic acid, methylene
chloride and ammonium hydroxide were all purchased from Thermo Fisher Scientific. Sheep
plasma was obtained from Carolina Biological Supply Company (Burlington, NC).
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Sample preparation
Cathinone, mephedrone and MDPV solutions (10, 50, 100, 250, 400 and 500ng/mL) were
prepared by spiking 1.0mg/mL methanol intermediates derived from reference standards into
water for EMIT analysis and methanol/mobile phase A for pre-SPE neat calibration curves.
SPE trial samples were spiked at the same concentration as neat samples and extracted from
methanol/mobile phase A and sheep plasma separately using standard extraction protocols
provided by the respective cartridge manufacturers (Table 1). Prior to extraction the spiked
plasma samples were treated with 1N acetic acid (1 part of plasma with 2 parts of 1N acetic
acid), vortexed for 10 seconds and centrifuged for 5 minutes at 13,000 rpm. Only the
supernatants were retrieved and subjected to extraction.
In the standard addition trial an initial calibration curve was prepared by spiking both cathinone
and mephedrone at 0, 10, 33 and 100ng/mL into sheep plasma. The Phenomenex Strata X-Drug
B column extraction protocol was performed and the eluents were then separated into six
separate aliquots. Each aliquot was then spiked with a mixture of cathinone and mephedrone at
0, 10, 40, 80, 100 and 200ng/mL and 25ng/mL mephedrone d3 (internal standard).
Solid phase extraction (SPE)
The sample prep extraction procedures used were obtained from Phenomenex and Supelco
(Table 1).
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Column Type

Column
Conditioning/Equilibration

Supel-Select HLB

Strata X-C

Strata X-Drug B

2mL methanol

2mL methanol

2mL methanol

2mL water

2mL acidified

2mL water

water
Sample Loading

1mL Sample

1mL Sample

1mL Sample

Wash 1

2mL

2 mL of 0.1 N

2 mL of 1 N acetate

HCl in water

acid

2mL Water: methanol:

2mL 0.1 N HCl

2mL methanol

ammonium hydroxide

in methanol

Water: methanol:
ammonium hydroxide
(93:5:2)
Wash 2

(78:20:2)
Dry by vacuum

10 minutes

10 minutes

Elute

2 mL Methanol: 1 N

2 mL 5%

2 mL of Methylene

acetic acid (95:5)

Ammonium

chloride/Isopropanol/

hydroxide in

Ammonium hydroxide

methanol

(80:18:2; V/V/V)

Table 1: Solid Phase Extraction protocol
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After extraction, eluents were spiked with 100µl of 2% hydrochloric acid in methanol and dried
under Turbo Vac at 50oC for 60 minutes. Mobile phase A (1ml) was used to reconstitute the
samples. The samples were then transferred into LC vials (150µl) for LC-MS/MS analysis.
Enzymatic Multiplied Immunoassay Technology (EMIT)
EMIT is a rapid and reliable screening procedure for illicit substances in biological specimens.
An immunoassay for drug testing is a test using antibodies to detect the presence of drugs and
other substances in urine or serum. Each antibody is specific to particular drug, drug class, or
their metabolites. Viva-Jr® Drug testing system (Siemens, Newark, DE) used in this study was
calibrated according to the manufacturer’s instructions. Level 3 calibrator was used as cutoff
control. Level 0 calibrator as negative control and Level 5 calibrator as positive control were
analyzed to verify correct instrument calibration.
Liquid chromatography
A Shimadzu LCMS 8030 Triple Quadrupole spectrometer was used for analysis. The analytical
column used was a Phenomenex KinetexTM C18 100x2.1 mm, 1.7um column at 30o C. Gradient
mobile phase system was applied for chemical separation with mobile phase A (0.1% formic
acid in water) and mobile phase B (0.1% formic acid in acetonitrile). The initial composition was
5% B, increased from 5 to 40 % B over 3 minutes, from 40 to 90% B over 30 seconds, and
returned to initial condition (5% B) over 30 seconds. Autosampler injections of 10uL were set at
15 o C with needle wash in 100% methanol.

Mass spectrometry

18

Electrospray ionization source equipped in Shimadzu LCMS 8030 Triple Quadrupole
spectrometer was operated in the positive ionization mode. The spray voltage was 4.5 kV.
Desolvation line (DL capillary) temperature was 250 oC and heating block temperature was 400 o
C. Nebulizing nitrogen gas was at a flow of 2 L/min with a drying gas flow of 15L/min. A
multiple reaction monitoring (MRM) optimization protocol was developed for analytes and
internal standard (Table 2).

Table 2: Optimized MRM parameters for cathinone, mephedrone and mephedrone d3.
Identification criteria of LC-MS/MS
Retention time (RT) and the ratio of the abundance of two product ions (qualitative and
quantitative) were used to identify peaks. RT must be within ± 0.2 minute of average calibrator
RT. The ratio of two MRN transition ions (quantitative ion and qualitative ion) detected for each
analyte must be within ± 20% of ratio obtained from calibrator.

Results
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Enzyme Multiplied Immunoassay Technique (EMIT) Analysis
Immunoassay has been commonly used as a screening test to classify drugs in biological
specimen. The Viva-Jr® Drug testing system (Siemens, Newark, DE) was used in this study to
carry out the enzyme multiplied immunoassay. The instrument employs a quartz-iodine source
(12v-20w) for wavelength selection and a photometric range of -0.1 – 2.0 absorbance units. The
system is also equipped with a multitude of reagents held at 8-12 o C that are used in various
screening procedures. For this experiment, two assays were chosen to run on four synthetic
cathinones; cathinone, mephedrone, MDPV and 4-methylephedrine. The amphetamine assay
which has three cutoffs 300, 500 and 1000 ng/ml d-methamphetamine and the ecstasy assay
which has two cutoffs 300 and 500 ng/ml MDMA were selected.
Viva-Jr EMIT - Amphetamine/Ecstasy panel assay
ug/ml

cathinone

mephedrone

4-methylephedrine

MDPV

0.5

negative

negative

negative

negative

1

negative

negative

negative

negative

2

negative

negative

negative

negative

20

negative

negative

negative

negative

100

negative

negative

negative

negative

200

negative

negative

negative

negative

Table 3: Viva-Jr EMIT Amphetamine and Ecstasy panel results
Negative results were obtained for each drug screened at concentrations of 0.5, 1, 2, 20, 100 and
200 µg/ml (Table 3). Cross-reactivity is based on the structural similarity between the four
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analytes and d-methamphetamine and MDMA (Figure 2). Cross reactivity with either screen at
each cutoff level for all drugs was not detected.

Mephedrone

Cathinone

Amphetamine

MDPV

4-Methylephedrine

MDMA
Figure 2. Structural similarity of analytes and competing reagents
Documentation provided by Siemens lists structurally related compounds and respective
concentrations necessary to cross-react with each assay (cathinone > 100ng/ml) (Siemens
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Healthcare Diagnostics Inc., 2011). Concentrations of 2,000x greater failed to produce the
necessary binding to achieve a measurable response.

22

LC-MS/MS method development
Before studying process efficiency and alternative quantification technique, LC-MSMS method
was set up to separate and detect cathinone, mephedrone, and mephedrone d 3. Respective
chromatographs of cathinone, mephedrone and mephedrone d3 by LC were shown in Figure 3
with cathinone eluted at 1.303 minutes, mephedrone at 1.991 minutes, and mephedrone d 3 at
1.988 minutes.

1.303
Cathinone

1.991
Mephedrone

1.988
Mephedrone d3

Figure 3: Representative chromatographs of cathinone, mephedrone, and mephedrone d 3 by
Shimadzu LCMS 8030 Triple Quadrupole spectrometer.
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Shimadzu LCMS 8030 Triple Quadrupole spectrometer was operated in multiple reaction
monitoring (MRM) mode. The energies which produced the two most abundant protonated ions
(quantitative ion and qualitative ion) were chosen to obtain the best m/z values. The most critical
parameters needed for successful MS detection and quantification are ionization mode, Q1
voltage, collision energy, desolvation gas flow, source temperature, and Q3 voltage. In this
study, electrospray ionization (ESI) in positive polarity was employed. Specific MRM conditions
were detailed in the method section. Representative mass spectra were shown in Figure 4. The
ratio of quantitative ion to qualitative ion was in 20% error range for analysis.
Cathinone

105

117

Mephedrone

91

145
Mephedrone d3

119

163

Figure 4: Representative mass spectra of cathinone, mephedrone, and mephedrone d3.
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Extraction process efficiency experiment for different solid phase extraction (SPE) cartridges
SPE has been commonly used in forensic toxicology field for sample preparation to purify,
concentrate, or decontaminate the target analytes. Various commercial SPE cartridges are
available for different types of analyte extraction. Choosing an SPE cartridge that is optimal for
the target analyte is an essential step of efficient extraction. In the study, three different SPE
cartridges have been selected --- Phenomenex Strata X-C, Phenomenex Strata X-Drug B,
and Supelco Supel®-Select HLB. These cartridges have different packing materials with
different chemistry. Therefore the extraction mechanism is different between these cartridges.
Three SPE cartridges; Supelco HLB, Phenomenex Strata X C and Phenomenex Strata X Drug B
were assessed for optimal recovery of each analyte spiked in sheep plasma. Extraction process
efficiency of each cartridge was based on the recovery of extracted samples at 10 and 100 ng/mL
(Figure 5 & 6). The recovery was measured by dividing the calculated drug concentration by the
true drug concentration based on calibration curves in Figure 7 and Figure 8. This experiment
was conducted at least twice.
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Recovery of Cathione after SPE Extration
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0

Supalco HLB

10 ng/ml

32.2

100 ng/ml

14.5

Strata X C

Strata X Drug B
205.8

45.0

95.5

Figure 5: Recovery of cathinone (10 ng/ml and 100 ng/ml) in plasma extracted by Phenomenex
Strata X-C, Phenomenex Strata X-Drug B, and Supelco Supel®-Select HLB.
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250

Recovery of Mephedrone after SPE Extration
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Supalco HLB
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17.2
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Strata X Drug B

196.8
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Figure 6: Recovery of mephedrone (10 ng/ml and 100 ng/ml) in plasma extracted by
Phenomenex Strata X-C, Phenomenex Strata X-Drug B, and Supelco Supel®-Select HLB.

Recovery rates for samples extracted by Phenomenex Strata X-C and Supelco Supel®-Select
HLB cartridges were found to be significantly low for cathinone and mephedrone at both
concentrations. Phenomenex Strata X-Drug B cartridge was found to generate greater recovery
rates as compared with the other two types of SPE cartridges. Because of this all other samples
of the study were extracted using the Phenomenex Strata X-Drug B cartridge. The recovery of
drugs extracted by Phenomenex Strata X-Drug B cartridges were however found to be twice as
high as neat samples at 10ng/ml for both drugs and greater than 139% at 100ng/mL in
mephedrone samples. Both experiments demonstrated the significance of matrix effects in SPE
efficiency.

A six-point calibration curve of neat samples was prepared for cathinone and mephedrone as a
basis of comparison for extracted samples. The six calibrators (10, 50, 100, 250, 400, 500 ng/ml)
were set up by spiking the chemicals into mobile phase A and product ion abundances were used
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to construct a linear curve. LC-MSMS results were used to set up the calibration curves for
cathinone (Figure 7) and mephedrone (Figure 8). The R2 values for cathinone and mephedrone
were observed as 0.986 and 0.960 respectively.
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Figure 7: Calibration curve of cathinone

Mephedrone Calibration Curve
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Figure 8: Calibration curve of mephedrone

27

A calibration curve was developed for mephedrone with samples in mobile phase A and samples
in sheep plasma that were subjected to SPE extraction. Both sets of samples yielded similar
results, in that retention time was unchanged for both compounds and linearity remained
constant. However, peak area was reduced in extracted calibrators (Figure 9). Average peak area
reduction was 18.84% with a maximum of 26.33% at 33ng/ml.

Figure 9: Calibration curves of neat and extracted mephedrone samples.
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Standard addition quantification technique for quantifying cathinone and mephedrone in
plasma by LC-MSMS
Standard addition quantification technique has been used as alternative quantification method for
LC-MSMS analysis when a good internal standard is not available. A standard addition spiking
protocol was developed to assess functionality and to test if the method can also mitigate matrix
effects observed in plasma samples. A calibration curve was created by spiking blank plasma
(with low, medium and high concentrations of drugs), extracting them and spiking the elutants
(with various concentrations of calibrators).
Blank plasma samples in this study were initially spiked with 0, 10, 33 and 100ng/mL cathinone
and mephedrone. Phenomenex Strata X-Drug B cartridges were used for the extraction.
Elutants were then spiked with 0, 10, 40, 80, 100 and 250 ng/mL cathinone and mephedrone as
well as 25ng/mL mephedrone d3 and MDPV d8 (internal standards).
LC-MSMS condition was set up as described before. Positive electrospray ionization was
employed and no precursor ions were used in analysis for any of the compounds in this study.
The most abundant product ions for cathinone and mephedrone were 117 and 145 respectively.
These two were used as primary quantifiers. Additional less abundant secondary transition ions
104 for cathinone and 90 for mephedrone were analyzed to obtain ion ratios. Internal standard
product ions 163 and 174 were used for mephedrone d3 and MDPV d8 respectively.
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a.

b.
Figure 10: Standard addition method mass spec abundance values (A.U.) for cathinone primary
and secondary quantifier ions (a.) 117.00 & (b.) 104.00.
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Figure 11: Standard addition method calibration curves for cathinone
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Recovery Rate of Cathinone in Plasma (Calculated by Standard addition Method)
Matrix

Calibration
curve

X value
when
Y=0

Mobile Phase

y = 15056x

0.755

A

+ 11361

ng/ml

Plasma

Y = 15765

0.755

X + 116422

ng/ml

Y = 12855

21.15

21.15 – 7.38

X + 271850

ng/ml

= 13.76

116422)/12855

ng/ml

= 12.09 ng/ml

0 ng/ml
Plasma with
10 ng/ml

Plasma with
33 ng/ml

Plasma with
100 ng/ml

Drug conc.
(ng/ml)

%
Rec.

Y value
when
X=0

Drug conc.
(ng/ml)

%
Rec.

11361

116422

137.6

239359

271850-

Y= 14171 X

38.28

38.28 – 7.38

+ 542465

ng/ml

= 30.90

116422)/14171

ng/ml

= 30.06 ng/ml

93.6

542465

Y= 14906 X

110.96

110.96–

+ 1653920

ng/ml

7.38= 103.57

116422)/14906

ng/ml

= 103.15 ng/ml

103.6

Table 4: Cathinone standard addition recovery calculations.
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1653920

(542465-

(1653920-

120.9

91.1

103.2

Percent recovery of initial cathinone concentration was 137.6, 93.6 and 103.6% for 10, 33 and
100ng/mL cathinone respectively using the standard addition method with the X-intercept and
120.9, 91.1 and 103.2% with calculations based on the Y-intercept (Table 4).

a.

b.
Figure 12: Standard addition method mass spec abundance values (A.U.) for mephedrone
primary and secondary quantifier ions (a.) 145.00 & (b.) 90.00.
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Calibration Curve of Mephedrone in Plasma
0 ng/ml
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Figure 13: Standard addition method calibration curves for mephedrone

Recovery Rate of Mephedrone in Plasma (Calculated by Standard addition Method)
Matrix

Calibration
curve

X value
when
Y=0

Mobile Phase

Y = 17282

7.20

A

X + 124380

ng/ml

Plasma

Y = 39587

30.63

X+

ng/ml

0 ng/ml

Drug conc.
(ng/ml)

%
Rec.

Y value
when
X=0
124380

1212540

1212540

33

Drug conc.
(ng/ml)

%
Rec.

Plasma with
10 ng/ml

Y = 35177

49.82

49.82 –

X+

ng/ml

30.63 =

1212540)/3517

19.19 ng/ml

7

1752490

191.9

1752490

(1752490 –

153.5

= 15.35 ng/ml
Plasma with
33 ng/ml

Y= 36238 X

65.52

65.52 –

+ 2374220

ng/ml

30.63 =

1212540)/3623

34.89 ng/ml

8

105.7

2374220

(2374220 –

97.1

= 32.05 ng/ml
Plasma with
100 ng/ml

Y= 37547 X

147.36

147.37 –

+ 5532760

ng/ml

30.63 =

1212540)/3754

116.73 ng/ml

7 = 115.06

116.7

5532760

(5532760 –

115.1

ng/ml

Table 5: Mephedrone standard addition recovery calculations.
Percent recovery of initial mephedrone concentration was 191.9, 105.7 and 116.7% for 10, 33
and 100ng/mL mephedrone respectively using the standard addition method with the X-intercept
and 153.5, 97.1 and 115.1% using the Y-intercept (Table 5).
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Figure 14: Standard addition method mass spec abundance values (A.U.) for mephedrone d 3
internal standard primary quantifier ion 163.00.

Figure 15: Cathinone recovery with internal standard and standard addition quantification.
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Figure 16: Mephedrone recovery with internal standard and standard addition quantification.

When using the internal standard ratio of mephedrone d3 percent recovery of initial cathinone
concentration was 165.21, 71.01 and 66.79% (Figure 15). Percent recovery of initial mephedrone
concentration using the same internal standard ratio was 201.23, 82.71 and 80.78% (Figure 16).
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Discussion
This study has outlined the problems associated in detecting cathinone and mephedrone (two of
the most basic molecules in this class) in standard immunoassay screening. The cross-reactivity
profiles of these compounds have proven to be insufficient at concentrations far beyond the
lethal limit to trigger positive results for standard amphetamine and ecstasy panels. Therefore
confirmatory testing is needed to accurately identify these compounds. Accurate qualitative and
quantitative analysis of a biological matrix is a multiple step process. Sample preparation
techniques like solid phase extraction are simple, quick and reproducible. They can be
incorporated in automated systems that reduce human error and allow for the simultaneous
cleanup of multiple samples. We have identified the need to properly select the correct sorbent
material by comparing the recovery of cathinone and mephedrone in three different SPE
cartridges. The Phenomenex Strata X-Drug B strong cation cartridge was found to have the best
retention profile for our analytes. The primary and secondary amines found on cathinone and
mephedrone respectively are thought to play the major role in the retention mechanism. Once
successfully separated from the majority of the biological material LCMS analysis can be
applied.
Neat samples of cathinone and mephedrone were infused post column to develop an optimized
acquisition method for both compounds. Precursor ions 150.10, 178.00 and 181.00 were detected
for cathinone, mephedrone and mephedrone d3. Primary and secondary transitions 117.00 and
104.85 were selected for cathinone, 145.00 and 90.95 for mephedrone and 163.05 and 118.90 for
mephedrone d3. These product ions were used as quantifiers and qualifiers.
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Calibration curves were developed at concentration ranges below and above the accepted cut-off
levels set by the Substance Abuse and Mental Health Services Administration (SAMSHA) for
our compounds (250ng/ml). These curves were analyzed to determine baseline ionization
abundances for our compounds. Calibration curves were also prepared at the same
concentrations in plasma. Recovery rates of our plasma samples differed from our baseline
analysis of neat samples, in that at low concentrations (10ng/ml) our ionization abundances were
significantly increased to 205.8% for cathinone and 196.8% for mephedrone. The matrix effects
that are observed in the analysis of biological samples differ depending on the specific matrix,
the compounds analyzed and their relative concentration. The specific mechanisms of matrix
interference is not fully understood and varies with each sample. The observed increase in ion
abundance at low concentrations highlights the influence of the plasma matrix on ionization
potential.
The internal standard quantification technique is an industry standard procedure and though there
are many advantages to its use our study aimed to examine the standard addition quantification
technique in an attempt to more accurately quantify cathinones at low concentrations. By
preparing a standard addition protocol that incorporated a parallel internal standard study we
were able to compare recovery rates for each method simultaneously. This eliminated the
potential influence of ionization fluctuation that can be experienced with modern mass
spectrometers.
Standard addition quantification along the X and Y axis proved to be more accurate in terms of
recovery than the internal standard across concentrations 10, 33 and 100ng/ml. Y-axis
calculations consistently produced the most accurate recovery for both analytes at each
concentration with an overall standard deviation along the Y-axis of 14.99% and 28.81%
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compared to 23.08% and 46.90% along the X-axis for cathinone and mephedrone respectively.
Ionization fluctuations between injections account for much more pronounced differences along
the X-axis and this is thought to be a major contributing factor to this reduction in accuracy.
Internal standard accuracy is largely dependent on the ionization potential of the analyte and
internal standard. Ideally a deuterated form of the analyte of interest should be used as an
internal standard because it can control for changes in ionization potential that are associated to
chemical structure and retention time. Because mephedrone is a more easily ionized than
cathinone using a mephedrone d3 internal standard can suppress accuracy. The increased
accuracy of mephedrone at levels 33 and 100ng/ml (82.71% and 80.78%) with the mephedrone
d3 internal standard demonstrates the similarities in ionization when compared to the same levels
of cathinone (71.01% and 66.79%) with the same internal standard.
The observed matrix effect at our lowest concentration (10ng/ml) accounted for ion enhancement
for both analytes. Internal standard quantification at this level was the least accurate (165.21%
and 201.23%) for cathinone and mephedrone respectively, whereas the standard addition
calculation along the Y-axis was the most accurate (120.9% and 153.5%). It is likely that the
lower ionization potential of cathinone played a significant role in this result.
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Conclusion

The health and legal problems associated with cathinones and other designer drugs are well
established. As law enforcement agencies and the health organizations continue to develop ways
to prevent the proliferation of these substances the scientific community must too continue to
produce accurate, consistent and precise data. Determining the link between these compounds
and forensic cases and overall public health is needed to gather this data. Therefore accurate
qualitative and quantitative analysis in biological samples is of the upmost importance to
furthering these goals.
In this study we’ve discussed the unique area of forensic toxicology that cathinones occupy.
We’ve outlined many of the historical dangers of designer drugs and many of the psychological
and physiological effects of cathinone use. The lack of immunoassay cross reactivity in standard
amphetamine/ecstasy panels show that modern drug screening techniques are insufficient in
detecting these compounds. Which underscores the need for accuracy in qualitative and
quantitative confirmatory testing.
This study explores some critical components of cathinone detection in biological samples, from
sample preparation to quantitative and qualitative confirmatory analysis. The findings support
the understanding that accurate quantification begins with proper sample preparation. In
choosing the most widely used industry standard sample prep method, solid phase extraction and
the industry “gold standard” in confirmatory testing, liquid chromatography and tandem mass
spectroscopy our results maintain relevance. By investigating the standard addition
quantification method we were able to improve recovery at a range of concentrations.
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Simultaneous analysis of the internal standard and standard addition techniques illustrates the
complications found in analyzing cathinones in low concentrations in the presence of a matrix.
The accuracy of using an internal standard is largely dependent on three components; chemical
structure, ionization potential and concentration. The use a deuterated form of an analyte as an
internal standard can control for chemical structure and ionization potential but the concentration
of the internal standard will always limit the upper and lower limits of quantitation. The findings
of this study demonstrate that accurate quantification by standard addition can be achieved
across a wide range of concentrations in the absence of a suitable internal standard.
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